5-fluoro-4-(8-fluoro-4-propan-2-yl-2,3-dihydro-1,4-benzoxazin-6-yl)-N-[(3E)-hexa-1,3,5-trien-3-yl]pyrimidin-2-amine

C21H22F2N4O — CID 169257431

IUPAC5-fluoro-4-(8-fluoro-4-propan-2-yl-2,3-dihydro-1,4-benzoxazin-6-yl)-N-[(3E)-hexa-1,3,5-trien-3-yl]pyrimidin-2-amine
SMILESC=C/C=C(\C=C)Nc1ncc(F)c(-c2cc(F)c3c(c2)N(C(C)C)CCO3)n1
InChIInChI=1S/C21H22F2N4O/c1-5-7-15(6-2)25-21-24-12-17(23)19(26-21)14-10-16(22)20-18(11-14)27(13(3)4)8-9-28-20/h5-7,10-13H,1-2,8-9H2,3-4H3,(H,24,25,26)/b15-7+
InChIKeyFCBYILQXUMKGNN-VIZOYTHASA-N
MW384.43 g/mol
LogP4.70
Rot. Bonds6

About 5-fluoro-4-(8-fluoro-4-propan-2-yl-2,3-dihydro-1,4-benzoxazin-6-yl)-N-[(3E)-hexa-1,3,5-trien-3-yl]pyrimidin-2-amine

5-fluoro-4-(8-fluoro-4-propan-2-yl-2,3-dihydro-1,4-benzoxazin-6-yl)-N-[(3E)-hexa-1,3,5-trien-3-yl]pyrimidin-2-amine (PubChem CID 169257431) has the molecular formula C21H22F2N4O and a molecular weight of 384.43 g/mol. Its IUPAC name is 5-fluoro-4-(8-fluoro-4-propan-2-yl-2,3-dihydro-1,4-benzoxazin-6-yl)-N-[(3E)-hexa-1,3,5-trien-3-yl]pyrimidin-2-amine.

Molecular Properties

Compound Name5-fluoro-4-(8-fluoro-4-propan-2-yl-2,3-dihydro-1,4-benzoxazin-6-yl)-N-[(3E)-hexa-1,3,5-trien-3-yl]pyrimidin-2-amine
PubChem CID169257431
Molecular FormulaC21H22F2N4O
Molecular Weight384.43 g/mol
Exact Mass384.18
IUPAC Name5-fluoro-4-(8-fluoro-4-propan-2-yl-2,3-dihydro-1,4-benzoxazin-6-yl)-N-[(3E)-hexa-1,3,5-trien-3-yl]pyrimidin-2-amine
SMILESC=C/C=C(\C=C)Nc1ncc(F)c(-c2cc(F)c3c(c2)N(C(C)C)CCO3)n1
InChIInChI=1S/C21H22F2N4O/c1-5-7-15(6-2)25-21-24-12-17(23)19(26-21)14-10-16(22)20-18(11-14)27(13(3)4)8-9-28-20/h5-7,10-13H,1-2,8-9H2,3-4H3,(H,24,25,26)/b15-7+
InChIKeyFCBYILQXUMKGNN-VIZOYTHASA-N
XLogP4.70
TPSA50.28 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds6
Heavy Atoms28
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500384.43
LogP ≤ 54.70
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'polyene', 'substructure': 'N/A'}

Analyze 5-fluoro-4-(8-fluoro-4-propan-2-yl-2,3-dihydro-1,4-benzoxazin-6-yl)-N-[(3E)-hexa-1,3,5-trien-3-yl]pyrimidin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-fluoro-4-(8-fluoro-4-propan-2-yl-2,3-dihydro-1,4-benzoxazin-6-yl)-N-[(3E)-hexa-1,3,5-trien-3-yl]pyrimidin-2-amine?
The IUPAC name of 5-fluoro-4-(8-fluoro-4-propan-2-yl-2,3-dihydro-1,4-benzoxazin-6-yl)-N-[(3E)-hexa-1,3,5-trien-3-yl]pyrimidin-2-amine (CID 169257431) is 5-fluoro-4-(8-fluoro-4-propan-2-yl-2,3-dihydro-1,4-benzoxazin-6-yl)-N-[(3E)-hexa-1,3,5-trien-3-yl]pyrimidin-2-amine.
What is the SMILES notation for 5-fluoro-4-(8-fluoro-4-propan-2-yl-2,3-dihydro-1,4-benzoxazin-6-yl)-N-[(3E)-hexa-1,3,5-trien-3-yl]pyrimidin-2-amine?
The canonical SMILES for 5-fluoro-4-(8-fluoro-4-propan-2-yl-2,3-dihydro-1,4-benzoxazin-6-yl)-N-[(3E)-hexa-1,3,5-trien-3-yl]pyrimidin-2-amine is C=C/C=C(\C=C)Nc1ncc(F)c(-c2cc(F)c3c(c2)N(C(C)C)CCO3)n1.
What is the InChIKey of 5-fluoro-4-(8-fluoro-4-propan-2-yl-2,3-dihydro-1,4-benzoxazin-6-yl)-N-[(3E)-hexa-1,3,5-trien-3-yl]pyrimidin-2-amine?
The InChIKey is FCBYILQXUMKGNN-VIZOYTHASA-N. The full InChI is InChI=1S/C21H22F2N4O/c1-5-7-15(6-2)25-21-24-12-17(23)19(26-21)14-10-16(22)20-18(11-14)27(13(3)4)8-9-28-20/h5-7,10-13H,1-2,8-9H2,3-4H3,(H,24,25,26)/b15-7+.
What are the key properties of 5-fluoro-4-(8-fluoro-4-propan-2-yl-2,3-dihydro-1,4-benzoxazin-6-yl)-N-[(3E)-hexa-1,3,5-trien-3-yl]pyrimidin-2-amine?
5-fluoro-4-(8-fluoro-4-propan-2-yl-2,3-dihydro-1,4-benzoxazin-6-yl)-N-[(3E)-hexa-1,3,5-trien-3-yl]pyrimidin-2-amine has a molecular weight of 384.43 g/mol, XLogP of 4.70, 6 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 5-fluoro-4-(8-fluoro-4-propan-2-yl-2,3-dihydro-1,4-benzoxazin-6-yl)-N-[(3E)-hexa-1,3,5-trien-3-yl]pyrimidin-2-amine is sourced from PubChem (CID 169257431), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).